SPI Healthcare
3.553,80
PKT
+36,60
PKT
+1,04
%
Werbung
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.06.23 | Novartis Buy | Jefferies & Company Inc. | |
30.05.23 | Roche Sell | Deutsche Bank AG | |
26.05.23 | Roche Underweight | JP Morgan Chase & Co. | |
24.05.23 | Roche Sell | Deutsche Bank AG | |
24.05.23 | Roche Equal Weight | Barclays Capital | |
19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
18.05.23 | Novartis Neutral | UBS AG | |
02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
28.04.23 | Roche Sell | Deutsche Bank AG | |
27.04.23 | Roche Outperform | Credit Suisse Group | |
27.04.23 | Roche Sell | Deutsche Bank AG | |
27.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
26.04.23 | Novartis Underperform | Credit Suisse Group | |
26.04.23 | Novartis Underweight | Barclays Capital | |
26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
26.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
26.04.23 | Novartis Buy | Deutsche Bank AG | |
26.04.23 | Roche Hold | Jefferies & Company Inc. | |
25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
21.04.23 | Roche Sell | Deutsche Bank AG | |
18.04.23 | Roche Hold | Jefferies & Company Inc. | |
18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
11.04.23 | Novartis Underweight | Barclays Capital | |
11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
05.04.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
28.03.23 | Novartis Neutral | UBS AG | |
28.03.23 | Novartis Hold | Deutsche Bank AG | |
27.03.23 | Roche Equal Weight | Barclays Capital | |
27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
14.03.23 | Novartis Sell | Deutsche Bank AG | |
08.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
03.03.23 | Roche Neutral | UBS AG | |
27.02.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
17.02.23 | Novartis Sell | Deutsche Bank AG | |
14.02.23 | Roche Sell | Deutsche Bank AG | |
13.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
13.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |